RT Book, Section
A1 Nast, Cynthia C.
A1 Adler, Sharon G.
A2 Lerma, Edgar V.
A2 Berns, Jeffrey S.
A2 Nissenson, Allen R.
SR Print(0)
ID 6336929
T1 Chapter 34. Thrombotic Microangiopathies
T2 CURRENT Diagnosis & Treatment: Nephrology & Hypertension
YR 2009
FD 2009
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-144787-4
LK accessmedicine.mhmedical.com/content.aspx?aid=6336929
RD 2024/04/20
AB The  thrombotic  microangiopathies  (TMAs)  are  classified  together  due  to  their  overlapping  clinical  and  morphologic  findings.  Their  major  clinical  manifestations  include  hemolytic  anemia,  microvascular  thrombosis,  and  thrombocytopenia.  Most  TMAs  have  renal  involvement  with  similar  morphologic  changes  in  the  kidney  reflecting  the  vasculopathy  these  lesions  share.  There  are  a  number  of  underlying  etiologic  factors  inducing  TMA  including  systemic  diseases,  infection,  and  medications,  which  are  summarized  in  Table  34–1.